Read more VitroScan's micro-tumor test accurately predicts chemotherapy response for ovarian cancer patients

9 September 2025

VitroScan is proud to announce the publication of a study showing its 3D ex vivo micro-tumor testing platform can accurately predict whether an ovarian cancer patient will respond to chemotherapy.

Read more